Agoracom: Small Cap Investment - Zenith Epigenetics - Re: Interim Financial .... Interim MD&A .... Reporting

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Interim Financial .... Interim MD&A .... Reporting

KOO-KOO2

Apr 05, 2024 05:49PM

Re: Interim Financial .... Interim MD&A .... Reporting

fuzzyjr

Apr 07, 2024 04:23PM

Re: Interim Financial .... Interim MD&A .... Reporting

chicagoest

Apr 07, 2024 11:51PM

fuzzyjr

Rank: Vice President [?]

Points: 5237 [?]

Votes: 36 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Interim Financial .... Interim MD&A .... Reporting

in response to

Re: Interim Financial .... Interim MD&A .... Reporting

chicagoest

posted on Apr 08, 2024 08:14AM

Thanks Chicagoest - looks like we may as well us one board given the obvious & overwhelming connection between these to. I will share your remark's to the rvx board as well. Thanks again!!

2 Recommendations

Reply New Message

Back To Forum List View

Please to post a reply